GlassScriptPhysician profile
Deborah D Mattson
NPI 1346394624
$16,715.76
in general payments reported to CMS, 2019-2025
33 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $983 · 2022: $1,224 · 2023: $6,737 · 2024: $7,432 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,437 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,175 · Consulting Fee: $3,330 · Travel and Lodging: $1,512 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,437.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,175.00 |
| Consulting Fee | $3,330.00 |
| Travel and Lodging | $1,512.10 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $10,661.44 | 2021-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $1,201.36 | 2021-2024 | Tezspire, Airsupra, Fasenra |
| Insmed, INC. | $602.75 | 2021-2024 | Arikayce |
| Amgen INC. | $417.28 | 2022-2024 | Tezspire, Tavneos |
| Regeneron Healthcare Solutions, INC. | $406.22 | 2021-2024 | Dupixent |
| Glaxosmithkline, LLC. | $374.13 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $336.01 | 2022-2024 | Glassia |
| Harmony Biosciences LLC | $314.23 | 2021-2024 | Wakix |
| Actelion Pharmaceuticals US, INC. | $303.48 | 2021-2024 | Uptravi, Opsumit |
| Grifols USA, LLC | $246.24 | 2021-2024 | Prolastin-C Liquid |
| Genzyme Corporation | $173.22 | 2022-2024 | |
| United Therapeutics Corporation | $152.51 | 2023-2024 | Tyvaso, Remodulin, Orenitram |
| Abbvie INC. | $151.88 | 2021-2024 | |
| Electromed, INC. | $144.41 | 2021-2024 | Smartvest |
| Neurocrine Biosciences, INC. | $135.41 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $114.51 | 2021-2023 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $108.61 | 2022-2024 | |
| Stryker Corporation | $99.86 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $93.94 | 2023-2024 | |
| Shionogi INC | $91.10 | 2022-2024 | Fetroja |
| Vapotherm INC | $84.44 | 2022-2023 | Vapotherm |
| Baxter Healthcare | $82.81 | 2022-2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Neurelis, INC. | $82.28 | 2024 | Valtoco |
| Merck Sharp & Dohme LLC | $69.94 | 2023-2024 | Winrevair |
| Avadel Cns Pharmaceuticals, LLC | $50.79 | 2024 | Lumryz |
| Inspire Medical Systems, INC. | $49.42 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $44.70 | 2021-2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $29.39 | 2021 | |
| Pulmonx Corporation | $28.06 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Inogen, INC. | $24.50 | 2022-2024 | |
| Pfizer INC. | $17.58 | 2023 | |
| Arbor Pharmaceuticals, INC. | $14.61 | 2021 | |
| 3b Medical, INC. | $8.65 | 2023 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Mattson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.